Existing investor Lux Capital led the round, with CVS Health Ventures joining as a new investor. The investment consists of $22 million in equity capital and a $20 million line of credit, bringing Waymark’s total capital raised to date to $87 million, according to an Oct. 18 news release.
Waymark enters into risk-based contracts with Medicaid managed care organizations to deliver community-based care and transition primary care practices to value-based arrangements. Currently, the company is supporting 50,000 Medicaid enrollees in Washington state and Virginia.
“This new financing will allow us to continue hiring and training a new community health workforce, expand PCP capacity, and ultimately deliver on our charter to improve access and quality of care for people receiving Medicaid,” Rajaie Batniji, MD, PhD, co-founder and CEO of Waymark, said.
According to a February article in Health Affairs, the top 10 MA-focused startups have raised more than $20 billion combined in venture funding, compared to $1.5 billion for the top 10 Medicaid-focused startups. But in 2021, CMS spent $734 billion on Medicaid, compared to $427 billion on MA in 2022.
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.